Vibroacoustic music therapy for postoperative delirium in the intensive care unit: A randomized controlled trial

Vibroacoustic music therapy for postoperative delirium in the intensive care unit: A randomized controlled trial - VIMUD-ICU

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00031985

Enrollment

106

Registered

2023-11-17

Start date

2023-09-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F05

Interventions

Group 1: Intervention group (3x individual music therapy sessions à 20-30 minutes on three consecutive days) Group 2: Control group (standard treatment)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria are met if participants:a) are at least 18 years old, b) German or English speaking, c) meet the criteria for postoperative delirium according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) or the International Classification of Diseases (ICD) 10 (codes: F05), d) score at least 4 on the Intensive Care Delirium Screening Checklist (IDCS), e) have legal guardianship/power of attorney, and f) are expected to be in intensive care for longer than 2 days.

Exclusion criteria

Exclusion criteria: Participation in the study is not possible, a) the presence of acute or chronic neurological or neurosurgical cerebral disease with cognitive impairment, b) the presence of acute or chronic psychiatric illness, c) the presence of current alcohol and/ or substance intoxication/overdose or withdrawal, d) death is expected within the next 72h after enrollment, e) recording of delirium is not possible (e.g., due to language barrier, aphasia, etc.), f) the patient is ventilated, g) the patient is pregnant or breastfeeding, g) there is a severe uncorrected hearing impairment, h) the patient is placed in an institution by court or official order, i) the patient has a personal relationship to the persons conducting the study (study management, study physicians, study therapists).

Design outcomes

Primary

Measure	Time frame
Delirium duration, using the Intensive Care Delirium Screening Checklist (ICDSC).	—

Secondary

Measure	Time frame
a) intensive care unit treatment duration since diagnosis of postoperative delirium, b) level of agitation as measured by Richmond Agitation and Sedation Scale (RASS). c) formal speech intelligibility, measured by audio recordings d) duration and dose of drug therapy for delirium e) duration and type of restraint measures f) subjective experience of patients, evaluation interview conducted two weeks after discharge from ICU Measurement during the process as routine measurement by nursing staff, as well as intra-individual pre-post measurement.	—

Measure

Time frame

a) intensive care unit treatment duration since diagnosis of postoperative delirium, b) level of agitation as measured by Richmond Agitation and Sedation Scale (RASS)*. c) formal speech intelligibility, measured by audio recordings d) duration and dose of drug therapy for delirium e) duration and type of restraint measures f) subjective experience of patients, evaluation interview conducted two weeks after discharge from ICU * Measurement during the process as routine measurement by nursing staff, as well as intra-individual pre-post measurement.

—

Countries

Germany

Contacts

Public ContactPetra Burzlaff

Universität Augsburg/ Forschungsbereich Musiktherapie / AYMGDALA

petra.burzlaff@uni-a.de+49 821-598/6140

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026